During antibody discovery, researchers characterize and optimize thousands of antibody molecules to select ideal drug candidates. Artificial intelligence/machine learning (AI/ML) technologies provide new opportunities for identifying and generating high-quality antibody drugs in less time. In this webinar brought to you by Integrated DNA Technologies, Charbel Eid from BigHat Biosciences will discuss an innovative AI/ML platform that guides antibody design and accelerates the discovery of better antibody therapeutics.
Topics to be covered
- A novel integrated AI/ML-wet lab platform
- How AI/ML enables faster antibody discovery
Monday, September 12th, 2022 | 2:30 PM - 3:30 PM Eastern Time
This webinar will be available to view live and on demand.
Charbel Eid, PhD
Head of Platform Development